FAKTOR-OPTIONSSCHEIN - INCYTE CO. Share Price

DE000SD416W8

Market Closed - Boerse Frankfurt Warrants 01:21:10 23/05/2024 am IST
11.2 ^EUR	-0.97%

Current month	-12.11%
1 month	-12.24%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Incyte Acquires 2 Office Buildings in Delaware	21/05	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	21/05	BU
Incyte to Present at Upcoming Investor Conference	21/05	BU
Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	15/05

More news

Quotes 5-day view

Date	Price	Change
22/24/22	11.18	-1.15%
21/24/21	11.31	-0.44%
20/24/20	11.36	+0.35%
17/24/17	11.32	-0.70%
16/24/16	11.4	+0.88%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 01:21 am IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SD416W
ISIN	DE000SD416W8
Date issued	29/03/2021
Strike	79.94 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.49 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	13.07 €
Lowest since issue	7.4 €
Spread	0.01 €
Spread %	0.09%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

58.2 USD

Average target price

73.65 USD

Spread / Average Target

+26.54%

Consensus